If you liked this article you might like

4 Biotech Names That Could Be M&A Targets
Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference
Merck Cancer Drug Test Sends Incyte Shares Higher
Biotech Stocks Surge Monday Amid Flurry of Deal Activity